Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Direct-to-consumer personal genome testing for age-related macular degeneration.

Investigative ophthalmology & visual science - 21 Aug 2014

Buitendijk Gabriëlle H S, Amin Najaf, Hofman Albert, van Duijn Cornelia M, Vingerling Johannes R, Klaver Caroline C W

Abstract excerpt

PURPOSE: Genetic testing may be the next step in clinical medicine for a more personalized approach in determining risk of disease. Direct-to-consumer (DTC) personal genome tests may fulfill this role. We explored the practicability and predictive value of DTC tests from four companies (23andMe, deCODEme, Easy DNA, Genetic Testing Laboratories) for AMD. METHODS: Body specimens of three individuals were collected...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome

Share to Genotype

Share to Incidence

Share to Macular Degeneration

Share to Netherlands

Share to Risk Assessment

Source

Identifiers

PMID: 25146986
DOI: 10.1167/iovs.14-15142

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Direct-to-consumer personal genome testing for age-related macular degeneration.PMID 25146986Read ↗

Limitations of direct-to-consumer genetic testing for age-related macular degeneration.Semantic proximity Read ↗

Variations in predicted risks in personal genome testing for common complex diseases.Semantic proximity Read ↗

Multigenic condition risk assessment in direct-to-consumer genomic services.Semantic proximity Read ↗

Concordance study of 3 direct-to-consumer genetic-testing services.Semantic proximity Read ↗

Genetic Risk Assessment of Degenerative Eye Disease (GRADE): Design of a prospective assessment of polygenic risk scores to predict diagnosis of glaucoma and age-related macular degeneration.Semantic proximity Read ↗

[The genome and the consumer].Semantic proximity Read ↗

Genetics and genetic testing for age-related macular degeneration.Semantic proximity Read ↗

DIRECT-TO-CONSUMER GENETIC TESTING: ETHICAL-LEGAL PERSPECTIVES AND PRACTICAL CONSIDERATIONSSemantic proximity Read ↗

Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe.Semantic proximity Read ↗

Direct-to-Consumer Personal Genome Testing and Cancer Risk PredictionSemantic proximity Read ↗

Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMeSemantic proximity Read ↗

The regulation of direct-to-consumer genetic tests.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.